Inflammatory bowel diseases (IBD), comprising Crohn disease (CD) and ulcerative colitis
(UC), are chronic inflammatory conditions of the gastrointestinal tract driven by inappropriate …

Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD)
characterized by intestinal inflammation. Increased intestinal levels of the proinflammatory …

Background The risk of lymphoma in patients with inflammatory bowel disease (IBD) treated
with anti‐TNF agents remains unclear. Aim To assess the comparative risk of lymphoma with …

Other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPD), a
category of immunodeficiencyassociated LPD according to the World Health Organization …

Inflammatory bowel disease (IBD), characterized primarily by gastrointestinal inflammation,
predominantly manifests as Crohn's disease (CD) and ulcerative colitis (UC). It is …

A ratiometric electrochemical sensor based on a carbon paste electrode modified with
quinazoline-engineered ZnFe Prussian blue analogue (PBA-qnz) was developed for the …

Description The purpose of this American Gastroenterological Association (AGA) Institute
Clinical Practice Update (CPU) Commentary is to discuss the risks of various malignancies …

Anti-tumor necrosis factor alpha (ATA) therapy plays a significant role in the treatment of
moderate to severe inflammatory bowel disease (IBD). There are concerns regarding risks …

The recent approval of new medications with novel mechanisms of action and emergence of
updated safety information for existing therapies has changed the treatment landscape of …

Simple Summary Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory
bowel diseases that affect the gut and extraintestinal organs. Preliminary evidence has …